跳至主要内容
临床试验/NCT00587093
NCT00587093已完成不适用

Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer

Memorial Sloan Kettering Cancer Center5 个研究点 分布在 1 个国家目标入组 669 人开始时间: 2001年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
669
试验地点
5
主要终点
To assess the efficacy of preoperative CT scan of the abdomen and pelvis in predicting optimal primary cytoreduction in advanced ovarian cancer.

研究概览

简要总结

The purpose of the research is to determine if blood tests and a CT scan done before surgery can predict how successful the surgery will be. In patients who have cancer of the ovary that has spread, it is hoped that the CT scan will be able to identify the various places where the cancer has spread so that additional surgeons can be available to help with the surgical procedure.

If you have confirmed stage 3 or 4 ovarian, fallopian tube, or primary peritoneal cancer, you may undergo a CT scan of the abdomen and pelvis after the surgery to compare how much cancer the surgeon thought was left after surgery to what is seen on CT scan. A CT scan of the chest will be done if your physician thinks it is necessary.

详细描述

This study is designed to assess the utility and impact of computed tomography (CT)scanning of the abdomen and pelvis and preoperative serum CA-125 levels in the management of patients undergoing surgery for presumed ovarian cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •All patients > 18 years of age undergoing surgery for presumed ovarian, fallopian tube, or primary peritoneal cancer.
  • •Patients must be medically and physically able to undergo general anesthesia and possible tumor debulking.
  • •Patients must read and sign informed consent form after the nature of the study has been fully explained.

排除标准

  • •Presence of clinically significant disease, allergy, or other disorder precluding the ability to safely perform CT scan of the abdomen and pelvis with oral and intravenous contrast.
  • •Vulnerable patients (minors, mentally retarded patients, prisoners, etc.)

研究组 & 干预措施

1

Other

CT scan and CA-125

干预措施: CA 125 and CT scan (Other)

结局指标

主要结局

To assess the efficacy of preoperative CT scan of the abdomen and pelvis in predicting optimal primary cytoreduction in advanced ovarian cancer.

时间窗: 7 - 35 days postop stage 3 or 4 disease CTscan have

次要结局

  • To evaluate the ability of preoperative serum CA-125 to predict optimal primary cytoreduction of advanced ovarian cancer.(Within 14 days prior to surgery)
  • To develop preoperative CT scan of the abdomen and pelvis and/or tumor marker criteria for ovarian cancer non-resectability (sub-optimal tumor cytoreduction).(3 years)
  • To determine the ability of preoperative CT scan of the abdomen and pelvis to provide useful information that will impact on surgical planning.(3 years)
  • To compare the intraoperative assessment of residual disease to that found on postoperative CT scan of the abdomen and pelvis, if scans are available for review.(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验